Protalix BioTherapeutics Inc. (AMEX:PLX)’s traded shares stood at 0.45 million during the last session, with the company’s beta value hitting 0.91. At the close of trading, the stock’s price was $1.15, to imply an increase of 1.77% or $0.02 in intraday trading. The PLX share’s 52-week high remains $3.55, putting it -208.7% down since that peak but still an impressive 5.22% since price per share fell to its 52-week low of $1.09. The company has a valuation of $84.01M, with an average of 348.75K shares over the past 3 months.

Protalix BioTherapeutics Inc. (AMEX:PLX) trade information

After registering a 1.77% upside in the last session, Protalix BioTherapeutics Inc. (PLX) has traded red over the past five days. The stock hit a weekly high of 1.2100, jumping 1.77% in its intraday price action. The 5-day price performance for the stock is -2.54%, and -14.18% over 30 days. With these gigs, the year-to-date price performance is -35.39%.

Protalix BioTherapeutics Inc. (PLX) estimates and forecasts

Looking at statistics comparing Protalix BioTherapeutics Inc. share performance against respective industry, we note that the company has outperformed competitors. Protalix BioTherapeutics Inc. (PLX) shares are -19.58% down over the last 6 months, with its year-to-date growth rate higher than industry average at 66.67% against 13.30%.

PLX Dividends

Protalix BioTherapeutics Inc. has its next earnings report out in May. However, it is important to take into account that this dividend yield ratio is just an indicator to only serve the purpose of guidance. Investors interested to invest in the stock should ponder company’s other fundamental and operations related aspects too. Protalix BioTherapeutics Inc. has a forward dividend ratio of 0, with the share yield ticking at 0.00% to continue the rising pattern observed over the past year. The company’s average dividend yield trailing the past 5-year period is 0.00%.